US45337C1027
US45337C1027
Incyte Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 22.86B EUR | 22.78B EUR | 18.82B EUR | 19.6B EUR |
Enterprise Value | 18.36B EUR | 18.84B EUR | 15.4B EUR | 16.54B EUR |
Valuation Multiples | ||||
Trailing P/E | 14.37x | 14.13x | 13.14x | 17.37x |
Forward P/E | 12.91x | -- | -- | -- |
Price to Sales | 3.93x | 3.91x | 3.51x | 4.79x |
Price to Book | 3.57x | 3.59x | 3.35x | 3.79x |
EV/Revenue | 3.15x | 3.24x | 2.87x | 4.05x |
EV/EBITDA | 9.45x | 9.03x | 9.16x | 12.76x |
Price to FCF (P/FCF) | 19.36x | 12.05x | 13.24x | 18.38x |
EV/FCF | 15.55x | 9.97x | 10.84x | 15.51x |
FCF Yield | 5.16% | 8.3% | 7.55% | 5.44% |